is glp 1 or glp 2 better for weight loss GLP-1 receptor agonists and metabolic health Part 1 of a 3-Part

The incidence risk ratio (IRR) was 0.82 for continuous GLP-1RA use, 0.88 for interrupted use, and 0.96 for discontinued use, relative to sulfonylurea use

Patient Prefer

The overall hazard ratio (HR) estimate was 0.59 (95% CI 0.400.79), indicating that tirzepatide resulted from a significant reduction in the risk of MACE-4 compared to the control group [21]

The US prescribing information for tirzepatide carries a black box warning for the risk of thyroid C-cell tumors

When someone loses a meaningful amount of weight during a claim, it can weaken several common insurance defenses: 1) Your injury is caused by obesity, not the accident. Weight loss challenges that narrative

Good luck getting enough protein on that kind of diet, good luck